flufenamic acid has been researched along with Amyloid Neuropathy Type 1 in 2 studies
Flufenamic Acid: An anthranilic acid derivative with analgesic, anti-inflammatory, and antipyretic properties. It is used in musculoskeletal and joint disorders and administered by mouth and topically. (From Martindale, The Extra Pharmacopoeia, 30th ed, p16)
flufenamic acid : An aromatic amino acid consisting of anthranilic acid carrying an N-(trifluoromethyl)phenyl substituent. An analgesic and anti-inflammatory, it is used in rheumatic disorders.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Connelly, S | 1 |
| Mortenson, DE | 1 |
| Choi, S | 1 |
| Wilson, IA | 1 |
| Powers, ET | 1 |
| Kelly, JW | 2 |
| Johnson, SM | 1 |
| Tojo, K | 1 |
| Sekijima, Y | 1 |
| Ikeda, S | 1 |
2 other studies available for flufenamic acid and Amyloid Neuropathy Type 1
| Article | Year |
|---|---|
Semi-quantitative models for identifying potent and selective transthyretin amyloidogenesis inhibitors.
Topics: Amyloid Neuropathies, Familial; Computer Simulation; Drug Design; Humans; Molecular Docking Simulati | 2017 |
Diflunisal stabilizes familial amyloid polyneuropathy-associated transthyretin variant tetramers in serum against dissociation required for amyloidogenesis.
Topics: Adult; Aged; Amyloid beta-Peptides; Amyloid Neuropathies, Familial; Anti-Inflammatory Agents, Non-St | 2006 |